We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biomarker in Adolescence Linked to Early Mortality

By LabMedica International staff writers
Posted on 27 Sep 2019
Print article
Image: Examples of erythrocyte sedimentation rates (ESR) from normal to pathological conditions. This test indirectly measures the degree of inflammation present in the body (Photo courtesy of The Netherland Association for Hematology).
Image: Examples of erythrocyte sedimentation rates (ESR) from normal to pathological conditions. This test indirectly measures the degree of inflammation present in the body (Photo courtesy of The Netherland Association for Hematology).
Inflammation is part of the complex biological response of body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, and is a protective response involving immune cells, blood vessels, and molecular mediators.

Inflammation during late adolescence may be associated with early death from cancer and cardiovascular disease (CVD). Despite increasing interest in the role of childhood and adolescent exposures in later-life disease, little is known about the long-term implications of early inflammation.

An international team of scientists led by the Memorial Sloan Kettering Cancer Center (New York, NY, USA) investigated the potential link between inflammation in late adolescence and death. The study included 106,120 seemingly Swedish healthy men who had undergone medical examination to assess their ability to carry out military service. Of these, 105,460 (99.4%) were aged 18 to 20 years at the time of examination.

Inflammation was measured by erythrocyte sedimentation rate (ESR), a nonspecific marker of inflammation. Erythrocyte sedimentation rate was categorized as low (≤10 mm/h), moderate (>10-<15 mm/h), and high (≥15 mm/h); the threshold from moderate to high ESR corresponds to the clinical cutoff for normal ESR among adolescents and men in this age group. Men were observed for death until January 1, 2010, unless censored because of emigration. Underlying causes of death included cancer (n = 1,105), cardiovascular disease (CVD) (n = 874), alcohol or drugs (n = 280), and suicide, traffic accidents, or falls (n = 1,502).

The team reported that after adjusting for potential confounders including age, erythrocyte volume fraction, household crowding, systolic and diastolic blood pressure, muscular strength, physical working capacity, cognitive function, and body mass index, ESR was associated with overall mortality (high versus low ESR: multivariable-adjusted hazard ratio [HR], 1.36; 95% confidence interval [CI], 1.11 - 1.67). ESR was also linked to death from cancer (HR, 1.78; 95% CI, 1.23 - 2.59) and CVD (HR, 1.54; 95% CI, 0.97 - 2.43).

The authors concluded that their results suggest that ESR among ostensibly healthy men in late adolescence marks something beyond that captured by manifested adolescent health conditions. Results demonstrate the need to better understand the role of subclinical early-life inflammation in relation to later-life health outcomes.

Elizabeth D. Kantor, PhD, MPH, the lead author of the study, said, “While the exact underlying mechanisms are unclear, inflammation has been implicated in the development of both cancer and atherosclerosis, and these data highlight the existence of detectable markers of premature mortality at an early stage of life.” The study was published on September 3, 2019, in the journal JAMA Pediatrics.

Related Links:
Memorial Sloan Kettering Cancer Center

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.